November 2026
- CHF 1.3 M
- Amount not disclosed
- CARECHF 2.3 M
CARE runs a health prevention platform used by more than 10,000 people.
- UNDAE ScienceCHF 1.2 M
UNDAE Science is developing Noctae, an at-home sleep analysis platform based on a sensor mat placed on the mattress.
- avaisorCHF 488,000
avaisor captures and transmits surgeons' reasoning, going beyond simple surgical video.
October 2026
- TrilliomeCHF 10,000
Trilliome develops patented ingredients that act on the gut-brain axis for metabolic and cognitive health.
- PolaSightCHF 100,000
PolaSight, a University of Bern spin-off, maps a fresh tissue sample in one minute during cancer surgery.
- JIVITAAmount not disclosed
JIVITA integrates complementary medicine care into the inpatient operations of partner clinics, including two Hirslanden clinics in Zurich.
- CHD (Connected Health Development)CHF 150,000
CHD, a medtech based on the Biopôle campus, is developing a connected textile belt to remotely monitor high-risk pregnancies.
- DistalmotionAmount not disclosed
Distalmotion is developing DEXTER, a robotic surgery system designed for ambulatory surgery centres.
- dEEGtalCHF 100,000
dEEGtal, based at the Wyss Center on the Campus Biotech, uses AI to analyse electroencephalograms and refine epilepsy diagnosis.
- AVEAAmount not disclosed
AVEA develops science-based food supplements and longevity products, and generated CHF 21 million in revenue in 2025.
- ph. (KA-EX)Amount not disclosed
The company ph.
- DeepPsyCHF 2 M
DeepPsy extracts depression-related biomarkers from EEG and ECG to help clinicians choose a treatment.
- Elysia SolutionsAmount not disclosed
Elysia Solutions uses AI to analyse individual biomarkers and formulate personalised prevention recommendations.
- PolaSightUSD 100,000
A University of Bern spin-off, PolaSight has developed PolaOne, a label-free imaging device that produces a tissue map in one minute during cancer surgery.
September 2026
- Bee PeopleCHF 1.3 M
Bee People manufactures food supplements and blends based on organic propolis and honey.
- Prevision MedicineUSD 5.4 M
Prevision Medicine tests living tumour cells from patients against a large library of treatments to guide therapy choice in oncology.
- AspivixEUR 837,800
Aspivix is developing carevix, a device intended to replace the Pozzi forceps for stabilising the cervix during gynaecological procedures.
- AseptuvaCHF 2.4 M
Aseptuva is developing far-UVC light disinfection technology at the catheter entry point to prevent hospital-acquired infections.
- Piomic MedicalUSD 25 M
An ETH Zurich start-up, Piomic Medical is developing COMS One, a portable, non-invasive device for treating chronic wounds.
- AeonAmount not disclosed
Aeon offers preventive whole-body health checks analysed by AI.
- OdneAmount not disclosed
Odne develops water-based endodontic treatment devices, already authorised by the FDA.
- Dexterous EndoscopesCHF 100,000
Dexterous Endoscopes is developing an endoscope that can switch from a flexible to a rigid state during a single procedure.
- Precisia CareCHF 100,000
Precisia Care analyses hospital data to anticipate patients' needs and the workload of nursing staff.
- Infera NeuroCHF 50,000
An EPFL spin-off, Infera Neuro designs neural decoding chips for non-invasive brain-computer interfaces intended to restore speech.
- SensoproAmount not disclosed
Sensopro manufactures coordination training devices used in fitness, therapy and elite sport.
- Chorus TreCHF 100,000
Chorus Tre, which stems from CHUV, is developing a secure platform to analyse sensitive medical data without it leaving the hospital.
- EndoboticaCHF 100,000
Endobotica, an EPFL project, is developing TREX, a teleoperated robotic system for more precisely removing clots during the treatment of ischaemic stroke.
- HeteroSightCHF 100,000
HeteroSight, which stems from CHUV, is developing an AI tool that reveals on a standard biopsy slide whether a tumour contains several genetically distinct zones.
- SixtineAICHF 100,000
SixtineAI is developing a platform that lets healthcare providers deploy and govern AI agents while keeping sensitive data under their control.
August 2026
- KOVE medicalCHF 1.6 M
A University of Zurich spin-off, KOVE medical develops an implantable device that closes the foetal membrane after in utero surgery to reduce the risk of preterm birth.
- DOCumenterCHF 50,000
DOCumenter automates medical documentation by transcribing consultations, generating documents and preparing TARDOC invoices.
- BeweCHF 250,000
A spin-off of the University of Fribourg, Bewe develops a neuroscience-based digital intervention against unhealthy food cravings.
- IndiviAmount not disclosed
Indivi develops smartphone-based assessments of motor and cognitive function to detect treatment effects earlier in neurology clinical trials.
- AVEAAmount not disclosed
AVEA develops science-based dietary supplements to support healthy ageing.
July 2026
- Ahead HealthUSD 10 M
Ahead Health offers preventive health check-ups combining whole-body MRI, blood tests and an AI platform.
- MedyriaCHF 3.5 M
Medyria develops sensor-tipped microcatheters that measure blood flow velocity for coronary diagnosis.
- Hilo (Aktiia)USD 19 M
Hilo, the brand of Aktiia, which originates from Swiss research, offers a connected bracelet and armband for blood pressure monitoring.
- CarewellCHF 1.5 M
Carewell offers healthcare institutions a staff replacement management platform combining an internal pool and a marketplace.
June 2026
- DetectraCHF 100,000
Detectra, which grew out of a CHUV project, remotely tracks joint inflammation in patients with arthritis using AI analysis of hand photos.
- calmeaCHF 150,000
calmea, an ETH spin-off, turns beds into sleep-tracking systems using a sensor module installed between the base and the frame.
May 2026
- Neurosoft BioelectronicsUSD 7.5 M
Neurosoft Bioelectronics develops flexible, stretchable brain-machine interfaces that have already been tested in 10 patients.
- Moonlight AIUSD 3.3 M
Moonlight AI develops image analysis software that detects genomic biomarkers in blood and cytology smears.
April 2026
- vVARDISAmount not disclosed
vVARDIS is developing Curodont, a non-invasive, peptide-based treatment for caries.
- UNBOOUND Medical TechnologiesCHF 100,000
A spin-off of Rockefeller University developed with the HUG, UNBOOUND offers SMELL-RS, a standardised measure of olfactory function.
- KA-EXCHF 4.8 M
KA-EX sells a patented recovery food supplement sold in Swiss supermarkets.
- TerapetEUR 772,000
A CERN spin-off based in Geneva, Terapet develops PET-type technologies to verify in vivo the dose delivered in proton therapy.
- ConnectomeUSD 2 M
Connectome develops a longitudinal, personalised measure of brain activity to track cognitive health.
March 2026
- PlairCHF 1 M
Plair sells RAPID-C+, a real-time viable particle counter for monitoring pharmaceutical cleanrooms.
- DiverssityCHF 50,000
Diverssity has developed “My Magic Room”, a mixed-reality therapeutic game for autistic teenagers.
- MoleSenseCHF 100,000
MoleSense is developing a skin patch that continuously monitors biomarkers to track high-risk pregnancies.
- Performance MouthGuardCHF 100,000
Performance MouthGuard 3D-prints custom mouthguards that reduce dental injuries and the risk of concussion.
- RiviaUSD 15 M
Rivia unifies clinical trial data and integrates AI agents into review workflows to reduce trial costs.
- Agora CareCHF 2.2 M
Agora Care runs a secure platform that centralises patients' medical data, with an AI assistant.
- docdok.healthAmount not disclosed
docdok.health is developing ePACURA, an AI-assisted solution for structuring and using medical documentation.
- PregnoliaAmount not disclosed
Pregnolia is developing a system that measures cervical stiffness to predict the risk of preterm birth.
- Polares MedicalUSD 50 M
Polares Medical is developing MRace, a transcatheter system for replacing the posterior leaflet of the mitral valve.
- XsensioUSD 7 M
Xsensio is developing Lab-on-Skin, a platform of wearable biosensors that continuously measure biochemical biomarkers.
February 2026
- PregnoliaAmount not disclosed
Pregnolia has developed a medical device that measures cervical stiffness to improve pregnancy monitoring.
- Clee MedicalAmount not disclosed
Clee Medical is developing a real-time, very high-resolution brain imaging platform for minimally invasive neurosurgery.
- KA-EXUSD 3.5 M
KA-EX sells a patented food supplement designed to reduce cortisol and improve recovery.
- Nose SwitzerlandCHF 20,000
Nose Switzerland combines an olfactory profiling kit with an app to tailor nutrition for cancer patients suffering from taste and smell disorders.
- AxmedUSD 6 M
Axmed runs a B2B platform for procuring and distributing essential medicines in low- and middle-income countries.
- CarewellCHF 200,000
Carewell is developing software that connects temporary healthcare staff with healthcare institutions.
- Berlin Heals HoldingUSD 10 M
Berlin Heals Holding, a Zug-based medtech company, is developing a micro-current cardiac implant (C-MIC) for heart failure.
January 2026
- ORamaVRUSD 4.5 M
ORamaVR develops a medical extended reality software platform combining AI and simulation for healthcare training and planning.
- OvivaUSD 220 M
Oviva provides reimbursed digital care for obesity and chronic weight-related conditions, notably in Germany, the United Kingdom and Switzerland.
- BabylatCHF 800,000
Babylat develops an automated device that enriches breast milk with protein and fat to feed premature infants.
- SIS MedicalAmount not disclosed
SIS Medical develops and distributes cardiovascular devices, including a very-high-pressure balloon for treating calcified coronary plaque.
- ImpliCHF 100,000
Impli develops an implantable biosensor that continuously tracks fertility hormones during IVF treatment.
- Ahead HealthUSD 6 M
Ahead Health brings MRI, blood tests and scans together in an AI preventive medicine platform operated with partner clinics.
- DistalmotionAmount not disclosed
Distalmotion develops DEXTER, a surgical robot designed for ambulatory surgery centres.
- MalaicaCHF 1.6 M
Malaica runs a pregnancy monitoring programme in Kenya that combines care, telemedicine and insurance.
December 2025
- LiomEUR 13.9 M
Liom (formerly Spiden) is developing a wristband that measures blood glucose non-invasively using Raman spectroscopy.
- GenknowmeCHF 500,000
Genknowme offers epigenetic blood tests that measure biological age and the impact of chronic stress, now reimbursed by the insurer KPT.
- Lighthouse TechCHF 816,000
The Ticino-based start-up Lighthouse Tech has developed TAMI, glasses that detect obstacles at head and torso height for visually impaired people.
- POSICSCHF 50,000
POSICS, a project from the Faculty of Science at the University of Geneva, develops a wireless camera for radio-guided cancer surgery, with 3D imaging and augmented reality.
- Testmate HealthAmount not disclosed
Testmate Health develops rapid, single-use molecular tests to screen for chlamydia and gonorrhoea without a laboratory.
- DigeHealthCHF 1.3 M
DigeHealth develops a wearable device that analyses bowel sounds to detect and monitor gastrointestinal complications.
- OncobitCHF 1.9 M
A University of Zurich spin-off, Oncobit develops a cancer monitoring platform based on detecting markers in liquid biopsies.
November 2025
- DistalmotionUSD 150 M
Distalmotion develops DEXTER, a surgical robot designed to fit into any operating theatre, including ambulatory surgery centres.
- IndiviCHF 15 M
Indivi develops digital biomarkers that turn smartphones and everyday devices into measurement tools for neuroscience drug development.
- AutonomyoEUR 1.4 M
An EPFL spin-off, Autonomyo develops Skywalk, a safety framework combined with an exoskeleton and a therapy platform for home rehabilitation.
- arcoris bioCHF 6.3 M
arcoris bio is developing MUSE, a nanotechnology platform for multiplexed biomarker detection in research and diagnostics.
- Emovo CareAmount not disclosed
Emovo Care develops wearable robots to help people with motor disorders, for example following a stroke.
- EvidoneAmount not disclosed
Evidone uses technology to improve the efficiency of operating theatre teams.
- Prevision MedicineAmount not disclosed
Prevision Medicine develops drug screening technologies to personalise cancer treatment.